This book focuses on the methodologies used to assess drug safety throughout the pharmaceutical lifecycle. It covers preclinical testing, clinical trials, and post-marketing surveillance to identify and mitigate toxic risks. The text highlights regulatory guidelines and the role of toxicology in ensuring medication safety. Ideal for pharmaceutical scientists and regulatory professionals, it advances knowledge in safety evaluations.
Blake Bender focuses on pharmaceutical toxicology, specifically evaluating the safety of drugs and their potential to cause harm. Blake has contributed to numerous studies on assessing drug safety and identifying risks associated with pharmaceutical products. He serves as an editor for books on drug safety and toxicology. His interests include the evaluation of new drugs for safety and their implications in forensic investigations.